TotalMarketCap

Tectonic Therapeutic

TECXNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$381.995 M

$19.54 -3.74%

Close of 6 Nov 2026

As of 6 Nov 2026, Tectonic Therapeutic (TECX) has a market capitalization of $382.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$74.2B

Loss-making

Shares outstanding

19,948,037

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #67Electra TherapeuticsETRA$449.4M
  2. #68Editas MedicineEDIT$390.9M
  3. #69Tectonic TherapeuticTECX$382.0M
  4. #70Allogene TherapeuticsALLO$380.0M
  5. #71TevogenTVGN$377.4M

What if Tectonic Therapeutic were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,444,388

Per share 73,920× higher

Bitcoin $1.53T

$78,153.33

Per share 4,000× higher

Apple $5.02T

$256,570.09

Per share 13,131× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Tectonic Therapeutic are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.